Nervio is a healthcare startup focused on revolutionizing intraoperative neuromonitoring (IONM) through its proprietary AI technology called AIM™. Launched in early 2020, the company addresses significant challenges in neurosurgery, where only 20% of surgeries are monitored due to a shortage of expert neurophysiologists. AIM™ leverages advanced machine learning algorithms to convert real-time surgical data into actionable alerts and recommendations, enhancing patient care while reducing the workload on existing professionals. Nervio aims to support the growing demand for neuromonitoring services, with a target market of over 700,000 surgeries annually in the US, contributing to a $3.3 billion industry that is expected to grow at a 4.9% CAGR.

nervio(נרוויו בע~מ)

nervio(נרוויו בע~מ)